Nifty
:
24005.85
Sensex
:
76922.64
140.10 (0.59%)
443.97 (0.58%)
Nifty
Sensex
:
:
24005.85
76922.64
140.10 (0.59%)
443.97 (0.58%)

Ajanta Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :
80/99

BSE: 532331 | NSE: AJANTPHARM

NSE BSE
3347.50
01-Jul-2026
  • Open
  • High
  • Low
  • Previous Close
  •  3422.7
  •  3506.9
  •  3316
  •  3422.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  99496
  •  335942567.3
  •  3506.9
  •  2329.9

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 41,813.45
  • 39.60
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 41,920.67
  • 0.84%
  • 9.24

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 66.25%
  • 0.17%
  • 6.35%
  • FII
  • DII
  • Others
  • 8.26%
  • 17.93%
  • 1.04%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.64
  • 10.29
  • 9.02

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.34
  • 8.46
  • 3.54

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.62
  • 8.18
  • 8.97

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 27.32
  • 34.32
  • 36.16

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.01
  • 6.90
  • 8.16

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.02
  • 21.31
  • 24.53

Earnings Forecasts:

(Updated: 27-06-2026)
Description
2026
2027
2028
2029
Adj EPS
14.79
84.17
96.56
110.92
P/E Ratio
226.34
39.77
34.67
30.18
Revenue
26.13
5366.98
6234.95
6974.18
EBITDA
7717.98
1449.42
1704.87
1952.24
Net Income
2157.03
1058.78
1215.28
1395.71
ROA
1530.23
19.97
19.25
18.84
P/B Ratio
-2.12
9.39
7.95
6.79
ROE
5.76
25.38
24.1
23.35
FCFF
22.82
544.73
812.08
1049.54
FCFF Yield
1102.68
1.38
2.06
2.66
Net Debt
2.8
-763.1
-698.02
-748.5
BVPS
-1580.7
356.36
421.2
492.73

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
1,421.64
1,170.41
21.47%
1,374.84
1,146.13
19.95%
1,353.73
1,186.64
14.08%
1,302.65
1,144.92
13.78%
Expenses
1,088.23
873.26
24.62%
992.60
825.30
20.27%
1,025.90
875.47
17.18%
951.30
814.57
16.79%
EBITDA
333.41
297.15
12.20%
382.24
320.83
19.14%
327.83
311.17
5.35%
351.35
330.35
6.36%
EBIDTM
23.45%
25.39%
27.80%
27.99%
24.22%
26.22%
26.97%
28.85%
Other Income
61.43
18.11
239.20%
24.97
30.44
-17.97%
59.34
19.48
204.62%
26.33
26.47
-0.53%
Interest
2.36
6.07
-61.12%
5.10
7.91
-35.52%
3.39
6.02
-43.69%
5.26
0.73
620.55%
Depreciation
45.37
39.78
14.05%
43.51
35.97
20.96%
42.97
34.39
24.95%
41.29
33.97
21.55%
PBT
347.11
269.41
28.84%
358.60
307.39
16.66%
340.81
290.24
17.42%
331.13
322.12
2.80%
Tax
80.41
44.15
82.13%
84.83
74.51
13.85%
80.62
73.76
9.30%
75.79
76.35
-0.73%
PAT
266.70
225.26
18.40%
273.77
232.88
17.56%
260.19
216.48
20.19%
255.34
245.77
3.89%
PATM
18.76%
19.25%
19.91%
20.32%
19.22%
18.24%
19.60%
21.47%
EPS
21.28
17.97
18.42%
21.84
18.58
17.55%
20.76
17.27
20.21%
20.37
19.61
3.88%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
-
5,452.86
4,648.10
4,208.71
3,742.64
3,340.99
2,889.69
2,587.87
2,055.37
2,125.76
1,983.26
Net Sales Growth
-
17.31%
10.44%
12.45%
12.02%
15.62%
11.66%
25.91%
-3.31%
7.19%
 
Cost Of Goods Sold
-
995.75
892.19
880.13
869.31
677.73
514.99
537.75
295.72
317.35
322.58
Gross Profit
-
4,457.11
3,755.91
3,328.58
2,873.33
2,663.26
2,374.70
2,050.12
1,759.65
1,808.41
1,660.68
GP Margin
-
81.74%
80.81%
79.09%
76.77%
79.71%
82.18%
79.22%
85.61%
85.07%
83.73%
Total Expenditure
-
4,058.03
3,388.60
3,036.77
2,959.39
2,411.70
1,891.13
1,904.55
1,488.94
1,467.37
1,296.38
Power & Fuel Cost
-
73.29
70.34
66.57
65.71
54.38
43.70
38.88
32.65
27.42
18.70
% Of Sales
-
1.34%
1.51%
1.58%
1.76%
1.63%
1.51%
1.50%
1.59%
1.29%
0.94%
Employee Cost
-
1,291.15
1,089.69
900.34
785.14
645.78
548.25
485.59
430.71
376.47
295.42
% Of Sales
-
23.68%
23.44%
21.39%
20.98%
19.33%
18.97%
18.76%
20.96%
17.71%
14.90%
Manufacturing Exp.
-
355.00
322.39
303.29
320.81
275.42
226.20
204.81
174.78
215.80
192.70
% Of Sales
-
6.51%
6.94%
7.21%
8.57%
8.24%
7.83%
7.91%
8.50%
10.15%
9.72%
General & Admin Exp.
-
487.54
435.55
382.26
365.86
300.83
131.64
159.49
149.90
131.92
92.02
% Of Sales
-
8.94%
9.37%
9.08%
9.78%
9.00%
4.56%
6.16%
7.29%
6.21%
4.64%
Selling & Distn. Exp.
-
651.20
482.41
417.54
463.94
400.29
374.73
413.70
320.99
306.30
270.92
% Of Sales
-
11.94%
10.38%
9.92%
12.40%
11.98%
12.97%
15.99%
15.62%
14.41%
13.66%
Miscellaneous Exp.
-
204.10
96.03
86.64
88.62
57.27
51.62
64.33
84.19
92.11
270.92
% Of Sales
-
3.74%
2.07%
2.06%
2.37%
1.71%
1.79%
2.49%
4.10%
4.33%
5.25%
EBITDA
-
1,394.83
1,259.50
1,171.94
783.25
929.29
998.56
683.32
566.43
658.39
686.88
EBITDA Margin
-
25.58%
27.10%
27.85%
20.93%
27.81%
34.56%
26.40%
27.56%
30.97%
34.63%
Other Income
-
172.07
94.50
84.60
98.64
115.68
25.98
92.19
21.08
24.16
23.86
Interest
-
16.11
20.73
7.21
5.84
10.20
8.27
11.91
1.16
0.41
1.36
Depreciation
-
173.14
144.11
135.40
130.80
125.29
116.09
95.71
72.08
59.59
61.21
PBT
-
1,377.65
1,189.16
1,113.93
745.25
909.48
900.18
667.89
514.27
622.55
648.17
Tax
-
321.65
268.77
297.76
157.27
196.80
246.31
196.27
127.30
153.91
141.34
Tax Rate
-
23.35%
22.60%
26.73%
21.10%
21.64%
27.36%
29.56%
24.75%
24.72%
21.81%
PAT
-
1,056.00
920.39
816.17
587.98
712.68
653.87
467.70
386.97
468.64
506.83
PAT before Minority Interest
-
1,056.00
920.39
816.17
587.98
712.68
653.87
467.70
386.97
468.64
506.83
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
19.37%
19.80%
19.39%
15.71%
21.33%
22.63%
18.07%
18.83%
22.05%
25.56%
PAT Growth
-
14.73%
12.77%
38.81%
-17.50%
8.99%
39.81%
20.86%
-17.43%
-7.54%
 
EPS
-
84.55
73.69
65.35
47.08
57.06
52.35
37.45
30.98
37.52
40.58

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
4,527.09
3,790.29
3,567.36
3,387.99
3,264.34
2,995.63
2,598.87
2,245.21
2,041.37
1,567.69
Share Capital
25.07
25.07
25.27
25.27
17.17
17.39
17.54
17.54
17.69
17.69
Total Reserves
4,498.80
3,760.04
3,536.44
3,362.38
3,246.87
2,977.70
2,580.86
2,226.57
2,022.05
1,548.35
Non-Current Liabilities
32.52
42.13
40.82
177.38
285.02
274.55
227.61
162.23
38.56
8.90
Secured Loans
0.00
0.00
0.00
1.25
1.64
1.60
0.74
0.66
1.01
1.04
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
60.26
80.27
39.54
146.55
216.04
208.12
155.01
134.15
13.16
4.88
Current Liabilities
1,686.96
1,284.98
895.25
1,139.28
647.39
838.82
745.53
498.35
346.05
246.66
Trade Payables
544.30
454.20
463.20
422.77
327.17
373.86
362.34
225.18
249.63
178.18
Other Current Liabilities
628.68
478.02
369.52
669.42
301.47
214.14
180.12
111.45
63.95
46.33
Short Term Borrowings
206.89
0.00
0.00
0.00
0.00
0.00
42.85
33.34
0.00
0.00
Short Term Provisions
307.09
352.76
62.53
47.09
18.75
250.82
160.22
128.38
32.47
22.15
Total Liabilities
6,246.57
5,117.40
4,503.43
4,704.65
4,196.75
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25
Net Block
1,866.95
1,762.02
1,479.19
1,496.44
1,503.58
1,532.21
1,462.75
1,168.35
1,052.66
589.17
Gross Block
3,046.33
2,801.05
2,389.41
2,282.82
2,206.86
2,129.87
1,965.22
1,578.96
1,417.23
894.94
Accumulated Depreciation
1,179.38
1,039.03
910.22
786.38
703.28
597.66
502.47
410.61
364.57
305.77
Non Current Assets
2,239.93
1,985.49
1,773.02
1,870.65
1,932.29
1,891.22
1,790.94
1,605.27
1,202.36
972.65
Capital Work in Progress
258.05
176.27
256.45
209.47
152.86
108.19
131.86
261.61
61.33
254.22
Non Current Investment
28.50
25.24
18.58
25.10
25.10
0.00
12.28
12.99
7.58
0.00
Long Term Loans & Adv.
84.86
18.25
14.43
134.79
236.46
230.74
165.57
148.36
76.79
41.88
Other Non Current Assets
1.57
3.71
4.37
4.85
5.88
11.18
9.09
4.08
4.00
2.34
Current Assets
4,006.64
3,118.58
2,722.07
2,825.18
2,264.46
2,217.78
1,781.07
1,300.52
1,223.62
850.60
Current Investments
559.85
438.71
330.05
510.27
121.86
175.67
67.14
64.74
182.38
181.56
Inventories
938.54
903.85
828.36
815.63
791.07
766.47
495.68
435.71
350.63
211.02
Sundry Debtors
1,853.88
1,182.74
1,246.84
1,056.90
1,019.81
738.43
775.30
459.48
459.79
323.15
Cash & Bank
104.77
176.24
130.77
330.90
211.79
209.61
205.25
100.51
93.09
69.95
Other Current Assets
549.60
38.80
53.76
22.09
119.93
327.60
237.70
240.08
137.73
64.92
Short Term Loans & Adv.
496.98
378.24
132.29
89.39
85.14
275.55
182.96
143.45
23.11
56.29
Net Current Assets
2,319.68
1,833.60
1,826.82
1,685.90
1,617.07
1,378.96
1,035.54
802.17
877.57
603.94
Total Assets
6,246.57
5,104.07
4,495.09
4,695.83
4,196.75
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
529.19
1,157.23
785.07
792.11
561.71
576.31
456.77
374.51
281.12
609.29
PBT
1,377.65
1,189.16
1,113.93
745.25
909.48
900.18
663.97
514.27
622.56
648.17
Adjustment
163.46
112.11
83.03
131.30
91.75
115.27
70.79
61.93
52.48
86.33
Changes in Working Capital
-652.93
178.93
-99.76
66.85
-200.39
-208.75
-123.16
-83.46
-254.32
25.88
Cash after chg. in Working capital
888.18
1,480.20
1,097.20
943.40
800.84
806.70
611.60
492.74
420.72
760.38
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-358.99
-322.97
-312.13
-151.29
-239.13
-230.39
-154.83
-118.23
-139.60
-151.09
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-428.92
-376.52
65.39
-559.60
-74.10
-282.38
-224.40
-222.78
-256.11
-383.12
Net Fixed Assets
-318.55
-324.07
-156.03
-150.65
-121.31
-137.02
-244.98
-361.08
-327.21
-235.38
Net Investments
-124.40
-114.70
186.12
-388.41
-7.97
-71.11
-2.77
117.64
-1.82
-104.79
Others
14.03
62.25
35.30
-20.54
55.18
-74.25
23.35
20.66
72.92
-42.95
Cash from Financing Activity
-167.92
-733.41
-1,051.06
-108.20
-459.71
-318.29
-128.63
-147.46
-0.20
-201.77
Net Cash Inflow / Outflow
-67.65
47.30
-200.60
124.31
27.90
-24.36
103.74
4.27
24.81
24.40
Opening Cash & Equivalents
175.12
129.49
329.83
206.36
177.51
202.35
95.16
90.64
65.83
41.42
Closing Cash & Equivalent
107.47
176.79
129.23
330.67
205.41
177.99
198.90
94.91
90.64
65.82

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
362.19
303.04
282.89
269.07
254.80
230.83
297.80
257.19
231.78
178.14
ROA
18.59%
19.13%
17.73%
13.21%
17.16%
17.03%
14.44%
14.52%
22.06%
30.69%
ROE
25.42%
25.06%
23.49%
17.68%
22.77%
23.38%
19.32%
18.07%
25.98%
36.75%
ROCE
32.67%
32.87%
32.22%
22.57%
29.37%
32.20%
27.44%
23.84%
34.49%
45.74%
Fixed Asset Turnover
3.86
3.43
3.42
3.19
1.56
1.43
1.46
1.37
1.84
2.49
Receivable days
49.07
49.80
52.69
52.87
94.50
93.66
87.08
81.62
67.06
63.41
Inventory Days
29.77
35.51
37.60
40.91
83.71
78.09
65.68
69.82
48.10
37.89
Payable days
183.00
187.66
183.71
157.44
188.77
260.89
59.55
63.24
57.26
50.30
Cash Conversion Cycle
-104.16
-102.34
-93.41
-63.66
-10.56
-89.14
93.21
88.21
57.90
51.01
Total Debt/Equity
0.05
0.00
0.00
0.00
0.00
0.00
0.02
0.02
0.00
0.00
Interest Cover
86.52
58.36
155.50
128.61
90.16
109.85
56.75
444.34
1519.41
477.60

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Ajanta Pharma’s promoter sells stake worth Rs 1023.96 crore
    10th Jun 2026, 14:58 PM

    Ravi Agrawal Trust has sold 34.50 lakh equity shares, representing 2.76% of total shareholding, of the company

    Read More
  • Ajanta Pharma - Quarterly Results
    6th May 2026, 00:00 AM

    Read More
  • USFDA concludes inspection at Ajanta Pharma’s Paithan manufacturing facility
    22nd Apr 2026, 10:10 AM

    The inspection was conducted from April 13, 2026, to April 21, 2026

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.